The neurology devices market size has grown rapidly in recent years. It will grow from $20.09 billion in 2025 to $22.44 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rising prevalence of neurological disorders, expansion of neurosurgical capabilities in hospitals, increasing availability of advanced imaging technologies, growing demand for minimally invasive procedures, improvements in clinical outcomes of neurology devices.
The neurology devices market size is expected to see rapid growth in the next few years. It will grow to $35.94 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing investments in brain-computer interface research, rising adoption of precision neurology approaches, expansion of outpatient neurology treatment centers, growing demand for non-invasive neurodiagnostic tools, increasing focus on remote neurological monitoring. Major trends in the forecast period include increasing adoption of neurostimulation therapies, rising use of image-guided neurosurgical systems, growing integration of ai in neurological diagnostics, expansion of minimally invasive neurology procedures, enhanced focus on personalized neurological treatments.
Favorable government initiatives are anticipated to drive the expansion of the neurology device market in the coming years. Government initiatives for medical devices include policies, regulations, and programs designed to ensure the safety, quality, and innovation of healthcare products. Such initiatives can boost market growth by shaping regulations, funding research and development, providing financial incentives, expanding telemedicine, raising public health awareness, and enhancing overall healthcare access. For example, in October 2023, the Food and Drug Administration, a US-based federal agency under the Department of Health and Human Services, extended the Total Product Life Cycle Advisory Programme (TAP) to cover neurological and physical medicine devices, with the goal of accelerating technological progress in these fields. By the first quarter of 2025, the FDA intends to add four more offices to the program and enroll up to 65 additional devices. Consequently, supportive government initiatives are fostering the growth of the neurology device market.
Leading companies in the neurology devices market are advancing implantable wireless brain devices, transforming neurological treatment through real-time monitoring and brain-computer interfaces. These innovations emphasize minimally invasive techniques, improved patient outcomes, and personalized therapies. Advanced medical devices are sophisticated tools employing cutting-edge technology for diagnosis, therapy, or monitoring. For instance, in April 2024, Medtronic, an Ireland-based medical device company, introduced the NeuroSmart Portable Micro Electrode Recording (MER) Navigation System. This system enhances Deep Brain Stimulation (DBS) procedures for Parkinson's disease by enabling real-time, precise electrode placement with automatic navigation, resulting in improved patient outcomes and fewer side effects. Its portability and advanced features allow clinicians to deliver tailored treatments efficiently.
In November 2024, Nihon Kohden, a Japan-based provider of high-precision patient monitoring systems and neurological diagnostic equipment, acquired a 71.4% stake in NeuroAdvanced Corp. for an undisclosed sum. With this acquisition, Nihon Kohden intends to strengthen its position in the neurology devices market by combining its established EEG system expertise with Ad-Tech’s specialized intracranial electrodes, thereby broadening its capabilities in comprehensive epilepsy diagnostics and neurological care. NeuroAdvanced Corp. is a US-based manufacturer of specialized electrodes for long-term EEG monitoring, brain mapping, SEEG, and brain stimulation.
Major companies operating in the neurology devices market are Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Integra LifeSciences, Abbott Laboratories, LivaNova PLC, Integer, Penumbra Inc., B. Braun Group, Johnson & Johnson, W.L Gore, St. Jude Medical LLC, Parasym, Smiths Medical, Cizeta Surgical, Neuro France Implants, Ectron, Accentus Medical Ltd, Argonaut Therapeutics, Brainwave Discovery, Cerus Endovascular, Chronus Therapeutics, Natus Medical Incorporated, Cerenovus, Nevro, Aleva Neurotherapeutics SA, Cyberonics Inc.
North America was the largest region in the global neurology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the neurology devices market by increasing costs of imported electronic components, imaging sensors, surgical instruments, and precision manufacturing equipment used across neurostimulation, neurosurgery, and diagnostic devices. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-value medical components, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are raising device prices and extending procurement cycles. However, they are also encouraging localized manufacturing, regional supplier development, and increased investment in domestic medical device innovation.
The neurology devices market research report is one of a series of new reports that provides neurology devices market statistics, including neurology devices industry global market size, regional shares, competitors with a neurology devices market share, detailed neurology devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurology devices industry. This neurology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurology devices are employed for the diagnosis, prevention, and treatment of various neurological disorders, including Alzheimer's, spinal cord injury, traumatic brain injury, and conditions affecting hearing and sight for patients with limb loss or congenital limb differences.
The primary types of neurology devices include cerebrospinal fluid management (CSF) devices and equipment, interventional neurology devices and equipment, neurosurgery devices and equipment, and neurostimulation devices. Neurostimulation devices generate electrical impulses placed under the patient's skin in specific parts of the body. Expenditures for these devices come from both public and private sources. The products encompass Instruments Or Equipment and disposables. Various end-users, including hospitals, clinics, diagnostic laboratories, and others, are involved in the use of neurology devices.
The neurology devices market consists of sales of neuro thrombectomy devices, carotid artery stents, embolic coils, and support devices that are used to treat neurological disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neurology devices market size is expected to see rapid growth in the next few years. It will grow to $35.94 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing investments in brain-computer interface research, rising adoption of precision neurology approaches, expansion of outpatient neurology treatment centers, growing demand for non-invasive neurodiagnostic tools, increasing focus on remote neurological monitoring. Major trends in the forecast period include increasing adoption of neurostimulation therapies, rising use of image-guided neurosurgical systems, growing integration of ai in neurological diagnostics, expansion of minimally invasive neurology procedures, enhanced focus on personalized neurological treatments.
Favorable government initiatives are anticipated to drive the expansion of the neurology device market in the coming years. Government initiatives for medical devices include policies, regulations, and programs designed to ensure the safety, quality, and innovation of healthcare products. Such initiatives can boost market growth by shaping regulations, funding research and development, providing financial incentives, expanding telemedicine, raising public health awareness, and enhancing overall healthcare access. For example, in October 2023, the Food and Drug Administration, a US-based federal agency under the Department of Health and Human Services, extended the Total Product Life Cycle Advisory Programme (TAP) to cover neurological and physical medicine devices, with the goal of accelerating technological progress in these fields. By the first quarter of 2025, the FDA intends to add four more offices to the program and enroll up to 65 additional devices. Consequently, supportive government initiatives are fostering the growth of the neurology device market.
Leading companies in the neurology devices market are advancing implantable wireless brain devices, transforming neurological treatment through real-time monitoring and brain-computer interfaces. These innovations emphasize minimally invasive techniques, improved patient outcomes, and personalized therapies. Advanced medical devices are sophisticated tools employing cutting-edge technology for diagnosis, therapy, or monitoring. For instance, in April 2024, Medtronic, an Ireland-based medical device company, introduced the NeuroSmart Portable Micro Electrode Recording (MER) Navigation System. This system enhances Deep Brain Stimulation (DBS) procedures for Parkinson's disease by enabling real-time, precise electrode placement with automatic navigation, resulting in improved patient outcomes and fewer side effects. Its portability and advanced features allow clinicians to deliver tailored treatments efficiently.
In November 2024, Nihon Kohden, a Japan-based provider of high-precision patient monitoring systems and neurological diagnostic equipment, acquired a 71.4% stake in NeuroAdvanced Corp. for an undisclosed sum. With this acquisition, Nihon Kohden intends to strengthen its position in the neurology devices market by combining its established EEG system expertise with Ad-Tech’s specialized intracranial electrodes, thereby broadening its capabilities in comprehensive epilepsy diagnostics and neurological care. NeuroAdvanced Corp. is a US-based manufacturer of specialized electrodes for long-term EEG monitoring, brain mapping, SEEG, and brain stimulation.
Major companies operating in the neurology devices market are Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Integra LifeSciences, Abbott Laboratories, LivaNova PLC, Integer, Penumbra Inc., B. Braun Group, Johnson & Johnson, W.L Gore, St. Jude Medical LLC, Parasym, Smiths Medical, Cizeta Surgical, Neuro France Implants, Ectron, Accentus Medical Ltd, Argonaut Therapeutics, Brainwave Discovery, Cerus Endovascular, Chronus Therapeutics, Natus Medical Incorporated, Cerenovus, Nevro, Aleva Neurotherapeutics SA, Cyberonics Inc.
North America was the largest region in the global neurology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the neurology devices market by increasing costs of imported electronic components, imaging sensors, surgical instruments, and precision manufacturing equipment used across neurostimulation, neurosurgery, and diagnostic devices. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-value medical components, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are raising device prices and extending procurement cycles. However, they are also encouraging localized manufacturing, regional supplier development, and increased investment in domestic medical device innovation.
The neurology devices market research report is one of a series of new reports that provides neurology devices market statistics, including neurology devices industry global market size, regional shares, competitors with a neurology devices market share, detailed neurology devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurology devices industry. This neurology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurology devices are employed for the diagnosis, prevention, and treatment of various neurological disorders, including Alzheimer's, spinal cord injury, traumatic brain injury, and conditions affecting hearing and sight for patients with limb loss or congenital limb differences.
The primary types of neurology devices include cerebrospinal fluid management (CSF) devices and equipment, interventional neurology devices and equipment, neurosurgery devices and equipment, and neurostimulation devices. Neurostimulation devices generate electrical impulses placed under the patient's skin in specific parts of the body. Expenditures for these devices come from both public and private sources. The products encompass Instruments Or Equipment and disposables. Various end-users, including hospitals, clinics, diagnostic laboratories, and others, are involved in the use of neurology devices.
The neurology devices market consists of sales of neuro thrombectomy devices, carotid artery stents, embolic coils, and support devices that are used to treat neurological disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neurology Devices Market Characteristics
3. Neurology Devices Market Supply Chain Analysis
4. Global Neurology Devices Market Trends and Strategies
5. Neurology Devices Market Analysis of End Use Industries
7. Global Neurology Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neurology Devices Total Addressable Market (TAM) Analysis for the Market
9. Neurology Devices Market Segmentation
10. Neurology Devices Market Regional and Country Analysis
11. Asia-Pacific Neurology Devices Market
12. China Neurology Devices Market
13. India Neurology Devices Market
14. Japan Neurology Devices Market
15. Australia Neurology Devices Market
16. Indonesia Neurology Devices Market
17. South Korea Neurology Devices Market
18. Bangladesh Neurology Devices Market
19. Thailand Neurology Devices Market
20. Vietnam Neurology Devices Market
21. Malaysia Neurology Devices Market
22. Singapore Neurology Devices Market
23. Philippines Neurology Devices Market
24. Hong Kong Neurology Devices Market
25. New Zealand Neurology Devices Market
26. Taiwan Neurology Devices Market
27. South East Asia Neurology Devices Market
28. Western Europe Neurology Devices Market
29. UK Neurology Devices Market
30. Germany Neurology Devices Market
31. France Neurology Devices Market
32. Italy Neurology Devices Market
33. Spain Neurology Devices Market
34. Austria Neurology Devices Market
35. Belgium Neurology Devices Market
36. Denmark Neurology Devices Market
37. Finland Neurology Devices Market
38. Ireland Neurology Devices Market
39. Netherlands Neurology Devices Market
40. Norway Neurology Devices Market
41. Portugal Neurology Devices Market
42. Sweden Neurology Devices Market
42. Switzerland Neurology Devices Market
43. Eastern Europe Neurology Devices Market
44. Russia Neurology Devices Market
45. Czech Republic Neurology Devices Market
46. Poland Neurology Devices Market
47. Romania Neurology Devices Market
48. Ukraine Neurology Devices Market
49. North America Neurology Devices Market
50. USA Neurology Devices Market
51. Canada Neurology Devices Market
52. Mexico Neurology Devices Market
53. South America Neurology Devices Market
54. Brazil Neurology Devices Market
55. Chile Neurology Devices Market
56. Argentina Neurology Devices Market
57. Colombia Neurology Devices Market
58. Peru Neurology Devices Market
59. Middle East Neurology Devices Market
60. Saudi Arabia Neurology Devices Market
61. Israel Neurology Devices Market
62. Iran Neurology Devices Market
63. Turkey Neurology Devices Market
64. United Arab Emirates Neurology Devices Market
65. Africa Neurology Devices Market
66. Egypt Neurology Devices Market
67. Nigeria Neurology Devices Market
68. South Africa Neurology Devices Market
70. Neurology Devices Market Competitive Landscape and Company Profiles
71. Neurology Devices Market Other Major and Innovative Companies
74. Neurology Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Neurology Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neurology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neurology devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurology devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Cerebrospinal Fluid Management (CSF) Devices And Equipment; Interventional Neurology Devices And Equipment; Neurosurgery Devices And Equipment; Neurostimulation Devices2) By Type of Expenditure: Public; Private
3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Cerebrospinal Fluid Management (CSF) Devices And Equipment: CSF Shunts; CSF Drainage Systems; Ventriculostomy Devices2) By Interventional Neurology Devices And Equipment: Intracranial Stents; Embolic Coils; Neurovascular Catheters
3) By Neurosurgery Devices And Equipment: Surgical Microscopes; Surgical Navigation Systems; Neurosurgical Instruments
4) By Neurostimulation Devices: Deep Brain Stimulation Devices; Spinal Cord Stimulation Devices; Transcranial Magnetic Stimulation Devices
Companies Mentioned: Medtronic PLC; Stryker Corporation; Boston Scientific Corporation; Integra LifeSciences; Abbott Laboratories; LivaNova PLC; Integer; Penumbra Inc.; B. Braun Group; Johnson & Johnson; W.L Gore; St. Jude Medical LLC; Parasym; Smiths Medical; Cizeta Surgical; Neuro France Implants; Ectron; Accentus Medical Ltd; Argonaut Therapeutics; Brainwave Discovery; Cerus Endovascular; Chronus Therapeutics; Natus Medical Incorporated; Cerenovus; Nevro; Aleva Neurotherapeutics SA; Cyberonics Inc.
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neurology Devices market report include:- Medtronic PLC
- Stryker Corporation
- Boston Scientific Corporation
- Integra LifeSciences
- Abbott Laboratories
- LivaNova PLC
- Integer
- Penumbra Inc.
- B. Braun Group
- Johnson & Johnson
- W.L Gore
- St. Jude Medical LLC
- Parasym
- Smiths Medical
- Cizeta Surgical
- Neuro France Implants
- Ectron
- Accentus Medical Ltd
- Argonaut Therapeutics
- Brainwave Discovery
- Cerus Endovascular
- Chronus Therapeutics
- Natus Medical Incorporated
- Cerenovus
- Nevro
- Aleva Neurotherapeutics SA
- Cyberonics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 22.44 Billion |
| Forecasted Market Value ( USD | $ 35.94 Billion |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
